0
ARTICLE |

Chemotherapeutic agents against RNA viruses: ranks swelling

JAMA. 1983;249(8):989-991. doi:10.1001/jama.1983.03330320003001.
Text Size: A A A
Published online

ABSTRACT

The first antiviral agent licensed by the Food and Drug Administration for systemic use in the United States (October 1966) was amantadine hydrochloride, an agent that blocks infection by influenza A (and some influenza B) strains.

Yet, as recently as the influenza A epidemic of 1980, says R. Gordon Douglas, Jr, MD, chair of the Department of Medicine, Cornell University Medical College, New York, and physician-in-chief, New York Hospital, amantadine was not widely used due to a commonly held belief that synthetic agents directed against RNA viruses were not safe or effective (see accompanying story, p 991).

This attitude has begun to change. Declares Raphael Dolin, MD, professor of medicine at the University of Rochester School of Medicine and Dentistry, New York, "There are now a number of compounds that are promising, and the whole area of antiviral chemoprophylaxis is more established."

Two newer agents now in clinical trials have

Topics

Sign In to Access Full Content

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

Purchase Online Access to this article for 24 hours

Figures

Tables

References

CME
Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Sign In to Access Full Content

Related Content

Customize your page view by dragging & repositioning the boxes below.

Jobs
brightcove.createExperiences();